These findings define a novel TP53 mutation-Wnt/β-catenin-TP63-GPX4 signaling axis that promotes ferroptosis resistance in GBM and deepen our understanding of ferroptosis regulation in this malignancy. The gene discussed is TP53; the disease is glioblastoma.